Complex and hybrid N-glycans generated by N-acetylglucosaminyltransferase I (GlcNAcT-I), encoded by Mgat1, affect the functions of glycoproteins. We have previously shown that females with oocyte-specific deletion of a floxed Mgat1 gene using a zona pellucida protein 3 (ZP3)Cre transgene produce fewer pups primarily due to a reduction in ovulation rate. Here, we show that the ovulation rate of mutant females is decreased due to aberrant development of preovulatory follicles. After a superovulatory regime of 48 h pregnant mare's serum (PMSG) and 9 h human chorionic gonadotropin (hCG), mutant ovaries weighed less and contained ∼60% fewer preovulatory follicles and more atretic and abnormal follicles than controls. Unlike controls, a proportion of mutant follicles underwent premature luteinization. In addition, mutant preovulatory oocytes exhibited gross abnormalities with ∼36% being blebbed or zona-free. While 97% of wild-type oocytes had a perivitelline space at the preovulatory stage, ∼54% of mutant oocytes did not. The cumulus mass surrounding mutant oocytes was also smaller with a decreased number of proliferating cells compared with controls, although hyaluronan around mutant oocytes was similar to controls. In addition, cumulus cells surrounding mutant eggs were resistant to removal by either hyaluronidase or incubation with capacitated sperm. Therefore, the absence of complex and hybrid N-glycans on oocyte glycoproteins leads to abnormal folliculogenesis resulting in a decreased ovulation rate.
The development of a functional oocyte from the primordial to ovulatory stage, takes ∼3 weeks in female mice (Pedersen & Peters 1968, Peters 1969) or potentially longer as observed in rats (Hirshfield 1989). Each oocyte develops within a follicle which provides the appropriate environment for oogenesis. Each follicle develops independently of gonadotropins, from recruitment as a meiotically quiescent, primordial follicle through folliculogenesis to the late preantral stage when FSH is required. LH stimulates preovulatory follicle development, oocyte maturation, and ovulation. The oocyte, despite being meiotically quiescent throughout folliculogenesis until ovulation, has an active role in the development of the follicle. It is now clear that there is considerable oocyte–follicle communication that is essential for successful oogenesis, and that the oocyte carefully regulates the surrounding environment (Matzuk et al. 2002, Gilchrist et al. 2004, Hutt & Albertini 2007).
We have previously shown that female mice with a conditional Mgat1 gene deletion, which precludes the synthesis of hybrid and complex N-glycans solely in oocytes, have decreased fertility due to a decreased ovulation rate, and compromised preimplantation embryonic development (Shi et al. 2004). Hybrid and complex N-glycans are generated following the addition of N-acetylglucosamine (GlcNAc) by N-acetylglucosaminyltransferase I (GlcNAcT-I) to Man5GlcNAc2Asn at certain N-X-S/T sites in glycoproteins (Fig. 1). Mutant oocytes were generated by females carrying a floxed Mgat1 gene and a zona pellucida protein 3 (ZP3) Cre transgene (Shi et al. 2004). ZP3 is expressed from the primary stage of folliculogenesis (Philpott et al. 1987), 2–3 weeks prior to ovulation. Females with no complex or hybrid N-glycans on oocyte glycoproteins produce litters ∼50% smaller than controls. The decline in litter size is primarily due to a decrease in the number of eggs ovulated (Shi et al. 2004). The remaining reduction in fertility is due to aberrant preimplantation development in embryos generated from Mgat1F/F:ZP3Cre females. While about half the embryos generated by fertilization of mutant eggs develop aberrantly, ∼50% of these resume development upon implantation (Shi et al. 2004). The resumption of normal development demonstrates that the aberrant embryonic development during blastogenesis is not due to parthenogenic activation, or penetration of the modified mutant zona and fertilization by multiple sperm, because both of these events are lethal (Sun 2003, Kono et al. 2004, Findlay et al. 2007). Therefore, although complex and hybrid N-glycans are not essential for oogenesis, fertilization, or preimplantation embryonic development, they play functional role(s) in oogenesis and ovulation.
In this paper, we show that the follicles with oocytes lacking complex and hybrid N-glycans have aberrant preovulatory follicular development, reflected in reduced numbers of preovulatory follicles, morphological abnormalities, and premature luteinization. Mutant oocytes are also surrounded by a reduced number of proliferating cumulus cells and generate eggs with a small cumulus mass.
Reduced ovulatory response in oocytes lacking complex and hybrid N-glycans
To determine whether the decreased ovulation rate of Mgat1F/F:ZP3Cre females reported previously (Shi et al. 2004) is due to aberrant development of preovulatory follicles or impaired ovulation, the number of ovarian follicles was determined in ovaries collected from females treated with pregnant mare's serum (PMSG) for 48 h followed by human chorionic gonadotropin (hCG) for 9 h. Mutant ovaries from unstimulated females were of the same weight as control ovaries (Table 1). However, the weights of ovaries collected from Mgat1F/F:ZP3Cre females after the superovulatory regime were less than control ovaries (Table 1). To identify all preovulatory follicles, every unstained section from one Bouin's-fixed ovary from each mouse was examined by light microscopy. The mutant ovaries were found to contain significantly fewer preovulatory follicles than control ovaries (20.0±2.6 per control ovary (n=3) vs 8.2±2.7 per mutant ovary (n=5); P<0.001).
Ovary weights from unstimulated and hormone-stimulated Mgat1F/F:ZP3Cre and control female mice.
Values are mean±s.d. *P<0.05.
6.5-week littermates from two sets of parents.
7-week females from four sets of parents analyzed in Table 2.
Follicle counts of Mgat1F/F:ZP3Cre ovaries after hormone stimulation.
|Primary||Preantral (% atretic)||Antral (% atretic/abnormal)||Preovulatory (% atretic/abnormal)||Total|
|Control (n=3)||72.0±13.5||43.7±15.1 (8±8)||6.7±3.8 (32±16)||17.0±1.0 (8±14)||139.3±31.8|
|Mutant (n=5)||49.4±25.6||14.8±5.8 (9±6)||2.8±1.9 (37±41)||9.2±3.3 (27±21)a||76.2±24.5|
Follicles were counted in one ovary per mouse collected at 57 h after administration of PMSG at 0 h and hCG at 48 h. Values are mean ±s.d.
Abnormal preovulatory follicles included luteinizing follicles and corpora lutea containing an oocyte.
To determine the stage at which folliculogenesis was modified in Mgat1F/F:ZP3Cre females, follicles were counted and staged in every 15th section of the same Bouin's-fixed ovaries after staining with hematoxylin and eosin (H&E). The follicles were counted if the oocyte nucleus was visible, and preovulatory follicles were counted if the oocyte was clearly visible. The follicles were defined as normal, atretic, or otherwise abnormal. The decrease in ovary weight in Mgat1F/F:ZP3Cre females was reflected in a 58% decrease in the number of normal preovulatory follicles (controls: 15.7±2.5 (n=3), mutant: 6.6±2.9 (n=5)). The mutant ovaries contained fewer follicles in all categories compared with controls (Table 2). Interestingly, approximately two luteinizing follicles were present in each mutant ovary (n=5), whereas none were observed in control ovaries (n=3; Fig. 2B and C). The luteinizing granulosa cells of these follicles were larger and disorganized with the most luteinized cells being furthest from the oocyte (Fig. 2B′ and C′). The percent of normal preovulatory follicles versus atretic/abnormal preovulatory follicles in Mgat1 mutants was significantly different from controls (Table 2; P<0.0001, χ2-test). Overall, 27% of mutant follicles were lost from the growing pool by atresia or premature luteinization compared with 8% of control follicles.
Morphological analysis of preovulatory follicles with an oocyte lacking complex and hybrid N-glycans
Abnormalities of preovulatory follicles in Mgat1 mutant ovaries that were clearly not luteinizing or undergoing atresia were common. In thin sections of glutaraldehyde-fixed mutant ovaries, the second ovary obtained from the same mice as the Bouin's-fixed ovaries analyzed in Table 2, oocytes had misshapen zona pellucidae, cumulus cells were observed beneath the zona, and there were oocytes separated from their zona (Fig. 3A–D). To quantify the abnormalities, sections through the center of oocytes of preovulatory follicles from the Bouin's-fixed ovaries were stained with hematoxylin and periodic acid Schiff reagent (H&PAS) and examined. Since mutant ovaries contained fewer preovulatory follicles (between 5–11), an equivalent number of preovulatory follicles per control ovary (10–11 randomly selected) were selected for further analysis. The preovulatory follicles were classified as grossly abnormal if they contained blebbed or disintegrating oocytes, oocytes lacking a zona and/or cumulus mass, or oocytes with cumulus cells present beneath the zona (Fig. 3E–J). Mgat1 mutant follicles exhibited more than three times the number of gross abnormalities compared with controls (Fig. 3K).
Additional abnormalities in follicles with an Mgat1−/− oocyte
The preovulatory follicles not classified as grossly abnormal in Fig. 3 were analyzed further for PAS-positive vesicles, perivitelline space morphology, and cumulus mass size. Mgat1−/− preovulatory oocytes lacking hybrid and complex N-linked glycans contained large vesicles that reacted with the PAS reagent compared with the much smaller vesicles present in control oocytes (Fig. 4). PAS reacts with sugars and stains glycogen, zona proteins, and other glycoproteins.
All preovulatory follicles classed as normal in Fig. 3 were classified into one of four categories according to the morphology of the perivitelline space between the zona and the oocyte (Fig. 5A). The perivitelline space was either: 1) continuous and completely surrounded the oocyte; 2) a continuous space spanning ∼50% of the oocyte circumference; 3) ~50% discontinuous space surrounding the oocyte; or 4) absent. The vast majority of control oocytes were surrounded by a perivitelline space, either continuous or discontinuous. However, ∼50% of Mgat1 mutant oocytes lacked any evidence of a perivitelline space (Fig. 5B). Therefore, the distribution of Mgat1 mutant oocytes in each of the four categories was significantly altered compared with controls (P<0.0001; χ2-test). The transzonal processes (TZPs) connecting the oocyte and granulosa cells were visualized using transmission electron microscopy (Fig. 6A–D). The number of TZPs in mutant follicles was decreased compared with controls (Fig. 6E).
Expansion of the cumulus mass matrix
The cumulus mass surrounding the oocyte in Bouin's-fixed preovulatory follicles not classed as grossly abnormal in Fig. 3 appeared to be smaller in ovaries from Mgat1F/F:ZP3Cre females. Although a range in cumulus mass size was observed in both control and mutant ovaries, the three largest masses in mutant ovaries were clearly smaller than controls (Fig. 7A–F). To determine whether the cumulus mass was smaller due to a decrease in cell number, proliferating cumulus cells in Bouin's-fixed preovulatory ovarian sections detected by an antibody to proliferating cell nuclear antigen (PCNA) were counted (Fig. 7G–I). The number of PCNA-positive cells was significantly reduced in cumulus masses surrounding Mgat1−/− oocytes compared with controls (Fig. 7J).
To investigate the ability of cumulus cells surrounding mutant oocytes to undergo expansion, hyaluronan was examined by detection with hyaluronic acid-binding protein (HABP) in Bouin's-fixed preovulatory follicles classed as normal in Fig. 3. Hyaluronan is secreted by cumulus cells in response to stimulation by the oocyte and is essential for cumulus expansion. HABP staining intensity of the cumulus mass surrounding Mgat1−/− oocytes was equivalent to control oocytes at a range of concentrations of HABP (Fig. 8A–E and data not shown). HABP staining also revealed the size of the expanded extracellular matrix surrounding the oocyte. Mgat1 mutant cumulus masses were significantly smaller than wild type (Fig. 8F and G). To confirm that the reduced diameter of the Mgat1 mutant extracellular cumulus mass was not due to lack of a perivitelline space, the width of the cumulus matrix was measured. This was also reduced in Mgat1 mutant follicles (Fig. 8H and I). Therefore, the oocytes lacking complex and hybrid N-glycans stimulate hyaluronan secretion by cumulus cells, but the reduced number of proliferating cumulus cells surrounding mutant oocytes contributes to a decrease in the size of the cumulus mass of preovulatory oocytes.
Cumulus mass of ovulated eggs
Cumulus masses surrounding ovulated Mgat1 mutant eggs were also smaller demonstrating that the developmental defect visible in the ovary neither precluded ovulation nor collected by the fimbria into the oviduct (Fig. 9A and B). The smaller cumulus mass around ovulated Mgat1−/− eggs also indicates that cumulus modification occurring in the oviduct was not able to compensate for their decreased size. Furthermore, the cumulus complex that joined ovulated Mgat1 mutant eggs together was thinner compared with controls (Fig. 9C and D).
The modified cumulus of Mgat1 mutant eggs was also reflected in the finding that cumulus cells adjacent to the oocyte were resistant to removal by incubation with hyaluronidase (Shi et al. 2004). To determine whether these cumulus cells could be removed by sperm that contain multiple hyaluronidases and arylsulfatase A that have a role in cumulus dispersal (Kim et al. 2005, Miller et al. 2007, Reitinger et al. 2007, Wu et al. 2007), ovulated eggs were incubated with capacitated sperm. Even after 4 h of co-incubation, many of the cumulus cells surrounding Mgat1−/− eggs remained attached compared with the absence of virtually all cumulus cells on control eggs (Fig. 9E and F). The cumulus cells resistant to hyaluronidase were also not detached by calcium chelation using media containing EDTA or by decreasing the pH (data not shown). Therefore, despite hyaluronan being present in normal amounts, the cumulus cells on mutant eggs were resistant to removal by purified hyaluronidase and sperm.
Cumulus cell attachment to the ZP
Since cumulus cells attached to the zona of Mgat1−/− oocytes were resistant to removal by hyaluronidase, sperm, EDTA, and low pH, it was possible that they were attached by stray zona protein as occurs in ZP1-null females (Rankin et al. 1999). However, scanning electron microscopy (SEM) revealed the surface of Mgat1 mutant zona pellucida to be similar to wild type in appearance (Fig. 10A–C) despite the fragile, thin nature of the zona (Shi et al. 2004). These images also show that the resistance of cumulus cells to removal from Mgat1−/− eggs was not due to being retained by stray zona protein (Fig. 10A–C).
Oocyte-specific deletion of the Mgat1 gene causes a decrease in eggs ovulated and fertility (Shi et al. 2004). We show here that the decrease in the number of ovulated eggs is due to aberrant folliculogenesis. The follicle numbers at all stages were reduced in Mgat1 mutant ovaries. A decrease in primary follicles was unexpected since inactivation of the Mgat1 gene occurs at this stage initiated by the expression of ZP3Cre, and therefore follicle recruitment was expected to be the same in mutant and control females. It is possible that abnormal mutant follicles at later stages affect the initial recruitment of follicles. In fact, this may also be the basis of the variation in the number of antral follicles observed after treatment with PMSG alone. We previously reported that mutant and control ovaries had the same number of antral follicles at 48 h after PMSG treatment (Shi et al. 2004). However, further analysis of additional mice revealed that, although the average did not differ between nine mutant and eight control ovaries (data not shown), the variation in antral follicle number amongst mutant ovaries was large, precluding a definitive conclusion.
Despite the number of abnormal preovulatory follicles, follicles containing mutant oocytes do develop, respond to hCG, attain preovulatory status, and ovulate. These mutant eggs have a smaller cumulus cell mass with a reduced number of cumulus cells. However, this decreased size is not due to grossly abnormal secretion of hyaluronan, indicating that the signaling pathways that stimulate the secretion of hyaluronan are fully functional in oocytes with glycoproteins that lack complex and hybrid N-glycans. On the other hand, a proportion of follicles undergo premature luteinization, a phenomenon not commonly seen in controls. This indicates that the signals that originate from the oocyte and prevent granulosa cells undergoing luteolysis are modified.
The morphology of large antral follicles in Mgat1F/F:ZP3Cre females does not differ from controls except for the generation of a thinner zona pellucida (Shi et al. 2004). However, we show here that there were ∼3.5-fold more abnormal preovulatory follicles in mutant compared with control ovaries. Therefore, it appears that the later stages of follicular development are more sensitive to the absence of complex and hybrid N-glycans, since numerous abnormalities were apparent 9 h after treatment with hCG. The response to the preovulatory LH surge is initiated by secretion from the mural granulosa cells of EGF ligands that stimulate EGF receptors on cumulus cells (Park et al. 2004, Ashkenazi et al. 2005). This induces the retraction of TZPs from the oocyte by the cumulus cells, resumption of meiosis by the oocyte, germinal vesicle breakdown, and the expression of extracellular matrix proteins required for cumulus expansion by the cumulus cells. However, although oocyte maturation is triggered by the surge of LH from the pituitary, many of the subsequent maturation events are stimulated by the oocyte. Therefore, since the later stages of follicle development are defective in Mgat1 mutants, these data identify a role for complex or hybrid N-glycans on oocyte glycoproteins at these stages and in cumulus expansion. The synthesis of these N-glycans is initiated in the medial Golgi, and thus the folding and chaperone functions of N-glycans necessary for exit of glycoproteins from the endoplasmic reticulum and progression along the secretory pathway, are not affected by the Mgat1 mutation.
The oocyte plays an active role in the development of the follicle that surrounds and nurtures it (Matzuk et al. 2002, Gilchrist et al. 2004, Hutt & Albertini 2007). Growth differentiation factor 9 (GDF9) is an oocyte-specific glycoprotein (McPherron & Lee 1993) with N-linked glycans (Elvin et al. 1999). Mice lacking GDF9 are infertile with follicles unable to develop beyond the primary stage (Dong et al. 1996). GDF9 functions synergistically with bone morphogenetic protein 15 (BMP15; Yan et al. 2001) – another oocyte-specific glycoprotein (Dube et al. 1998, Hashimoto et al. 2005). Mice lacking BMP15 have decreased fertility, but fertility is decreased further if the females are also heterozygous for GDF9 and these females have cumulus expansion defects (Yan et al. 2001). Therefore, GDF9 and BMP15, being oocyte-specific glycoproteins involved in cumulus expansion, are potential candidates for giving rise to the Mgat1 mutant phenotype. However, GDF9 induces cumulus cells to express hyaluronan which is required for cumulus expansion (Elvin et al. 1999), and hyaluronan is present in equivalent amounts in Mgat1 mutant follicles to controls. This indicates that GDF9 and BMP15 signaling is functional and thus GDF9 and BMP15 are unlikely to be responsible for the Mgat1 mutant phenotype. However, the incidence of premature luteinization may indicate that the Smad4 signaling pathway has been affected by the loss of complex N-glycans from oocytes in some follicles since this also occurs in ovaries with a granulosa cell conditional deletion in Smad4 (Pangas et al. 2006). Cumulus cell differentiation is determined by proximity to the oocyte and the resulting gradient of influence (Diaz et al. 2007). Therefore the increased amount of luteinization furthest from the oocyte might reflect a defect in the prevention of luteinization by the oocyte.
The LH surge also stimulates the retraction of TZPs. The TZPs are microtubules that extend from the cumulus cells adjacent to the zona, penetrate through the zona pellucida, and terminate on the oocyte joining the two cells (Anderson & Albertini 1976). TZPs communicate with the oocyte via gap junctions comprising connexin-37 (Cx-37) expressed by the oocyte (Veitch et al. 2004). Cx-37 is not glycosylated and therefore could not have a direct role in the Mgat1 mutant phenotype. However, it has been shown that communication between the oocyte and the cumulus cells regulates meiotic maturation of the oocyte (De La Fuente & Eppig 2001). Therefore, the cumulus cells adjacent to the zona that cannot be removed by hyaluronidase on Mgat1 mutant oocytes may still be linked to the oocyte via TZPs. This connection could alter oocyte maturation and the later stages of follicular development and may be involved in the Mgat1 mutant phenotype.
Many Mgat1 mutant follicles also lack a perivitelline space. After the LH surge the TZPs, as extensions of cumulus cells, secrete extracellular matrix proteins required for cumulus expansion which contribute to the generation of the perivitelline space (Talbot & Dandekar 2003). The lack of a perivitelline space around some Mgat1 mutant oocytes could be, in part, due to the decrease in their TZPs. Furthermore, since the normal morphology of TZPs from mutant oocytes is modified, perhaps they are also not being appropriately retracted and are attaching the zona tightly to the surface of the oocyte. This could explain the resistance of cumulus cells to removal by hyaluronidase. Half the Mgat1 mutant preovulatory follicles lack a perivitelline space, and half the embryos generated from oocytes lacking complex N-glycans have aberrant preimplantation development (Shi et al. 2004). This correlation may indicate that the generation of a perivitelline space may be required for normal preimplantation embryogenesis. Indeed, the ability of an oocyte to form a perivitelline space has been linked with meiotic competence (Inoue et al. 2007).
The large PAS-positive vesicles in Mgat1−/− oocytes indicate aberrant secretion of glycoproteins. The identification of oocyte glycoprotein(s) responsible for the defects seen in Mgat1 mutants may be confounded due to the altered morphology of the zona pellucida. The Mgat1 mutant zona is thin and fragile but does contain all three ZP proteins (Shi et al. 2004). It seems unlikely that the thickness of the mutant zona on Mgat1−/− eggs contributes to the aberrant oogenesis and embryonic development observed in Mgat1 mutants since ZP1-null mice generate a thin zona but ovulate normal numbers of eggs (Rankin et al. 1999), and mice heterozygous for ZP3 generate a 50% thinner zona but fertility is unaffected (Wassarman et al. 1997). However, it is possible that the altered structure of the Mgat1 mutant zona has a modified function and may contribute, perhaps by limiting TZP abundance or release, to the compromised state of Mgat1−/− oocytes and/or ovulated eggs. Transmission electron microscopy revealed the decreased presence of TZPs in the mutant zona but does not reveal whether the change in TZP quantity is due to modifications in TZP generation by oocyte glycoproteins or the structure of the modified zona. It also does not reveal whether TZPs were released from mutant oocytes but remained trapped within the zona structure.
In summary, follicles containing oocytes lacking complex and hybrid N-glycans have defective follicle development leading to a significant decrease in preovulatory follicles and a decreased ovulation rate. Most follicles with a mutant oocyte that continue development to become ovulatory do not generate a normal perivitelline space, a defect that has been linked to meiotic incompetence (Inoue et al. 2007).
Materials and Methods
The mice were bred and maintained in the Institute for Animal Studies within the Albert Einstein College of Medicine. Female mice homozygous for a floxed (F) Mgat1 gene or heterozygotes with a floxed and null allele and carrying a ZP3Cre recombinase transgene in a 129/C57BL/6 mixed background (Shi et al. 2004) were used to generate oocytes lacking complex and hybrid N-glycans. The heterozygous Mgat1F/− females have no discernable phenotype (Shi et al. 2004). Mgat1F/F females lacking the ZP3Cre transgene were used as controls as we have shown that this transgene has no effect on fertility (Shi et al. 2004, Williams et al. 2007).
Hormonal stimulation protocol
To synchronize folliculogenesis or to obtain ovulated eggs, females were subjected to a superovulatory regime. Females were injected intraperitoneally with 5 IU of PMSG (Calbiochem, EMD Chemicals Inc., San Diego, CA, USA) followed by 5 IU of hCG (Sigma) after 46–48 h. Ovaries containing preovulatory follicles were collected 9 h after the hCG injection; all subsequent references to preovulatory follicles or ovaries refer to tissue collected after this treatment regime. Ovulated eggs were collected from the oviduct 14–16 h after the hCG treatment.
To determine the number of preovulatory follicles, females were treated with PMSG for 48 h and ovaries were collected 9 h after hCG administration. Female body and ovary weights were recorded. One ovary was fixed in Bouin's fixative and one in glutaraldehyde, as described below. The Bouin's ovary was fixed for ∼12 h at room temperature followed by three washes of 5 min with 70% v/v EtOH, and an overnight wash with fresh 70% v/v EtOH at 4 °C. The fixed ovaries were paraffin embedded, 3 μm serial sections were collected onto positively charged slides and heated at 62 °C for 1 h. Preovulatory follicles were counted in all unstained sections. To enable all follicle stages to be counted and staged, every 15th serial ovarian section (45 μm apart) was stained with H&E and analyzed. All non-preovulatory follicles (primary: stages 3a and 3b; preantral: 4, 5a, and 5b; antral: 6–8) in which the oocyte nucleus was visible were counted and staged according to Pedersen & Peters (1968), including those morphologically atretic or abnormal. All preovulatory follicles where the oocyte, but not necessarily the nucleus, was clearly visible were counted and abnormalities noted.
Sections through the middle of Bouin's-fixed preovulatory follicle oocytes were selected for staining with H&PAS (Sigma), PAS-positive vesicle analysis, perivitelline space analysis, PCNA expression, and HABP analysis. Since mutant ovaries contained less preovulatory follicles as determined by the counts of unstained sections, the number of control follicles stained with H&PAS for comparison with mutants was 10–11 per ovary, the maximum number found in a mutant ovary. To ensure that the control preovulatory follicles were chosen at random, the first 10–11 follicles identified were selected.
The second preovulatory ovary was fixed in 2.5% v/v glutaraldehyde in 0.1M sodium cacodylate for 1 h with agitation at room temperature, postfixed with 1% w/v osmium tetroxide followed by 1% uranyl acetate, dehydrated through a graded series of ethanol and embedded in LX112 resin (LADD Research Industries, Burlington, VT, USA). Sections of 1 μm were cut on a Reichert Ultracut UCT and stained with 1% w/v toluidine blue in 1% w/v sodium borate.
For transmission electron microscopy, ovaries from 5.5- to 10-week-old untreated mutant and control females were prepared as above. Ultrathin sections were cut on a Reichert Ultracut UCT, stained with uranyl acetate followed by lead citrate and viewed on a JEOL 1200EX transmission electron microscope at 80 kV. The TZPs were determined by measuring the area of the TZPs in the zona using NIH Image J. The image selected for TZP measurement contained the longest section of zona for each follicle.
Proliferating cell nuclear antigen
To determine the number of proliferating cells in the cumulus matrix, sections through the center of preovulatory oocytes were selected for PCNA staining. Bouin's-fixed, paraffin-embedded, 3 μm sections from ovaries of females treated with PMSG and hCG were dewaxed and rehydrated. Endogenous peroxidase was neutralized by incubating sections in 0.3% v/v H2O2 in methanol for 30 min at room temperature. The sections were washed twice for 5 min with PBS before blocking background staining with 2% w/v BSA/PBS for ≥1 h at room temperature on a slow platform shaker. The sections were incubated with anti-PCNA antibody (P8825; Sigma) diluted at 1:200 in 2% BSA/PBS in a humidified chamber for ≥1 h at room temperature; controls were incubated in 2% BSA/PBS. The sections were washed for 3 min with PBS three times before incubating with a goat antibody to mouse IgG conjugated to horse radish peroxidase (Zymed, San Francisco, CA, USA) diluted 1/200 in 2% BSA/PBS in a humidified chamber for ≥1 h at room temperature. The sections were washed for 3 min with PBS three times before staining with 3,3′-diaminobenzidine using a peroxidase substrate kit (SK-4100; Vector Labs, Burlingame, CA, USA). The reagent was prepared according to the manufacturer's instructions and all sections were exposed to the reagent for the same time within a single experiment before terminating the reaction by placing sections in distilled H2O. The optimum reaction time for visualizing PCNA-positive cells was determined using a control section in each experiment. The sections were counter-stained with hematoxylin, dehydrated and mounted using Permount (Fisher, Pittsburg, PA, USA).
Detection of cumulus mass hyaluronan
Hyaluronan (hyaluronic acid) in the cumulus mass of preovulatory follicles was detected with hyaluronic acid-binding protein (HABP) in paraffin-embedded ovary sections using immunofluorescence. Sections of 3 μm through the center of preovulatory oocytes in Bouin's-fixed ovaries from females treated with PMSG and hCG were dewaxed and rehydrated before incubation in 3% BSA/PBS for ≥1 h with agitation at room temperature to block non-specific binding sites. The sections were incubated with ∼100 μl diluted biotinylated HABP (400763-1; Seikagaku, Falmouth, MA, USA) at 0.5 μg/ml in 3% BSA/PBS for 2 h at room temperature; controls were incubated in 3% BSA/PBS. The sections were then washed with 3% BSA/PBS for 3 min at room temperature three times before incubation with 10 μg/ml Streptavadin Alexa Fluor @ 568 (Molecular Probes, Invitrogen, Carlsbad, CA, USA) in 3% BSA/PBS and incubated for 1 hour at room temperature. The sections were then washed, mounted using Gel/Mount (Biomeda corp., Foster City, CA, USA) and immediately photographed. To determine the size of the cumulus mass, photographs of preovulatory oocytes stained with HABP were printed. The diameter was determined from the average of two measurements taken perpendicular to each other across the center of the oocyte. The width of the cumulus mass was the average of four measurements of the cumulus thickness at four equally spaced locations around the oocyte.
Removal of cumulus cells by sperm
Females were treated with exogenous gonadotropins as described above, and eggs were collected from oviducts into M2 media (Specialty Media, Phillipsburg, NJ, USA) that had been equilibrated overnight at 37 °C 95% CO2 5% air. To obtain capacitated sperm, the cauda was dissected from C57BL/6 males and the sperm were squeezed out into M2 media. The sperm were incubated for 15 min to allow dissemination, before counting at 4 μm on a Coulter counter. The sperm were added to equilibriated media at 1 million/ml and incubated for 1 h to allow them to undergo capacitation. Oviducts containing ovulated eggs were obtained from superovulated females and added to the capacitated sperm. The eggs were released and the gametes were co-incubated for 4 h at 37 °C. At the end of the incubation period, eggs were transferred into separate dishes and photographed.
Collection of eggs for SEM
Oocytes with retained cumulus cells were examined by SEM. The females were injected intraperitoneally with 5 IU of PMSG followed by 5 IU of hCG 46 h later, and ovaries were collected after 9–12 h into Earle's balanced salt solution (EBSS; Gibco) containing 0.1% w/v polyvinylpyrrolidone (PVP) (EBSS/PVP). The largest follicles were punctured using fine dissecting needles to release oocyte cumulus complexes (OCCs) into the medium. Ovulated OCCs were also used. The OCCs collected from both follicles and oviducts were exposed to prolonged incubation (∼20–30 min) in EBSS/PVP containing 0.3 mg/ml hyaluronidase (Sigma) and protease inhibitors (Roche). The oocytes were washed with EBSS/PVP before fixation in 2.5% glutaraldehyde in 0.1M sodium cacodylate for 1 h at room temperature with agitation, dehydrated through a graded series of ethanol, critical point dried using liquid carbon dioxide in a Tousimis Samdri 790 Critical Point Dryer (Rockville, MD, USA), sputter coated with gold palladium in a Denton Vacuum Desk-1 sputter coater (Cherry Hill, NJ, USA). The ovaries were imaged in a JEOL JSM6400 scanning electron microscope (Peabody, MA, USA), using an accelerating voltage of 10 kV. The images were recorded with AnalySIS (Olympus Soft Imaging Systems GMBH, Lakewood, CO, USA).
Counts of PCNA-positive cells, cumulus diameter and width measurements, and preovulatory follicle classification were carried out blinded. All values are mean±s.d. Values were analyzed by two-tailed unpaired t-tests using Microsoft Excel Data Analysis Package. The distribution of the percent of follicles in each category of perivitelline space and of the percent of healthy preovulatory follicles versus atretic/abnormal were analyzed using the χ2-test ().
Declaration of interest
The authors declare no conflict of interest.
This work was supported by the National Institutes of Heath (RO1 30645 to P S) and partial support was provided by the Albert Einstein Cancer Center grant (PO1 13330).
We thank Wen Dong and Henry Kurniawan for their excellent technical assistance, Radma Mahmood and Rani Sellers of the AECOM Histopathology Facility for their advice and technical assistance, and the Analytical Imaging Facility for sectioning, toluidine staining, SEM and TEM.
AndersonEAlbertiniDF1976Gap junctions between the oocyte and companion follicle cells in the mammalian ovary. Journal of Cell Biology71680–686.
AshkenaziHCaoXMotolaSPoplikerMContiMTsafririA2005Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology14677–84.
DongJAlbertiniDFNishimoriKKumarTRLuNMatzukMM1996Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature383531–535.
DubeJLWangPElvinJLyonsKMCelesteAJMatzukMM1998The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Molecular Endocrinology121809–1817.
ElvinJAClarkATWangPWolfmanNMMatzukMM1999Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Molecular Endocrinology131035–1048.
FindlayJKGearMLIllingworthPJJunkSMKayGMackerrasAHPopeARothenfluhHSWiltonL2007Human embryo: a biological definition. Reproduction22905–911.
De La FuenteREppigJJ2001Transcriptional activity of the mouse oocyte genome: companion granulosa cells modulate transcription and chromatin remodeling. Developmental Biology229224–236.
GilchristRBRitterLJArmstrongDT2004Oocyte–somatic cell interactions during follicle development in mammals. Animal Reproduction Science82–83431–446.
HashimotoOMooreRKShimasakiS2005Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. PNAS1025426–5431.
HirshfieldAN1989Granulosa cell proliferation in very small follicles of cycling rats studied by long-term continuous tritiated-thymidine infusion. Biology of Reproduction41309–316.
InoueAAkiyamaTNagataMAokiF2007The perivitelline space-forming capacity of mouse oocytes is associated with meiotic competence. Journal of Reproduction and Development531043–1052.
KimEBabaDKimuraMYamashitaMKashiwabaraSBabaT2005Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. PNAS10218028–18033.
KonoTObataYWuQNiwaKOnoYYamamotoYParkESSeoJSOgawaH2004Birth of parthenogenetic mice that can develop to adulthood. Nature428860–864.
MatzukMMBurnsKHViveirosMMEppigJJ2002Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science2962178–2180.
McPherronACLeeSJ1993GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. Journal of Biological Chemistry2683444–3449.
MillerKAShaoMMartin-DeLeonPA2007Hyalp1 in murine sperm function: evidence for unique and overlapping functions with other reproductive hyaluronidases. Journal of Andrology2867–76.
PangasSALiXRobertsonEJMatzukMM2006Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Molecular Endocrinology201406–1422.
PhilpottCCRinguetteMJDeanJ1987Oocyte-specific expression and developmental regulation of ZP3, the sperm receptor of the mouse zona pellucida. Developmental Biology121568–575.
ReitingerSLaschoberGTFehrerCGreidererBLepperdingerG2007Mouse testicular hyaluronidase-like proteins SPAM1 and HYAL5 but not HYALP1 degrade hyaluronan. Biochemical Journal40179–85.
ShiSWilliamsSASeppoAKurniawanHChenWYeZMarthJDStanleyP2004Inactivation of the Mgat1 gene in oocytes impairs oogenesis, but embryos lacking complex and hybrid N-glycans develop and implant. Molecular and Cellular Biology249920–9929.
SunQY2003Cellular and molecular mechanisms leading to cortical reaction and polyspermy block in mammalian eggs. Microscopy Research and Technique61342–348.
VeitchGIGittensJEShaoQLairdDWKidderGM2004Selective assembly of connexin37 into heterocellular gap junctions at the oocyte/granulosa cell interface. Journal of Cell Science1172699–2707.
WassarmanPMQiHLitscherES1997Mutant female mice carrying a single mZP3 allele produce eggs with a thin zona pellucida, but reproduce normally. Proceedings. Biological Sciences/The Royal Society264323–328.
WilliamsSAXiaLCummingsRDMcEverRPStanleyP2007Fertilization in mouse does not require terminal galactose or N-acetylglucosamine on the zona pellucida glycans. Journal of Cell Science1201341–1349.
WuAAnupriwanAIamsaardSChakrabandhuKSantosDCRuparTTsangBKCarmonaETanphaichitrN2007Sperm surface arylsulfatase A can disperse the cumulus matrix of cumulus oocyte complexes. Journal of Cellular Physiology213201–211.
YanCWangPDeMayoJDeMayoFJElvinJACarinoCPrasadSVSkinnerSSDunbarBSDubeJL2001Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Molecular Endocrinology15854–866.
S A Williams is now at Department of Physiology, Anatomy and Genetics, Le Gros Clark Building, University of Oxford, South Parks Road, Oxford OX1 3QX, UK